Effect of Pexelizumab in Coronary Artery Bypass Graft Surgery With Extended Aortic Cross-Clamp Time

Annals of Thoracic Surgery

Volumn 82, Issue 3, 2006, Pages 781-789

  Smith, Peter K ^a   Carrier, Michel ^b   Chen, John C ^c   Haverich, Axel ^d   Levy, Jerrold H ^e   Menasché, Philippe ^f   Shernan, Stanton K ^g   Van de Werf, Frans ^h   Adams, Peter X ⁱ   Todaro, Thomas G ^j   Verrier, Edward ^k  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF HAWAII   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e EMORY UNIVERSITY HOSPITAL   (United States)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ ALEXION PHARMACEUTICALS   (United States)

^j PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5 INHIBITOR; PEXELIZUMAB; PLACEBO;

AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SURGICAL PATIENT; TIME; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; AORTA; BIOLOGICAL MARKERS; COMPLEMENT ACTIVATION; COMPLEMENT C5; CONSTRICTION; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; LIFE TABLES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747331917     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.02.024     Document Type: Article

References (32)

1. Takaba T., and Inoue K. Past and present in myocardial protection. Ann Thorac Cardiovasc Surg 6 (2000) 3-8
2. Alex J., Ansari J., Guerrero R., et al. Comparison of the immediate post-operative outcome of two different myocardial protection strategies. antegrade-retrograde cold St Thomas blood cardioplegia versus intermittent cross-clamp fibrillation. Interact CardioVasc Thorac Surg 2 (2003) 584-588
3. Islamoglu F., Reyhanoglu H., Berber O., et al. Predictors of outcome after coronary artery bypass grafting in patients older than 75 years of age. Med Sci Monit 9 (2003) CR369-CR376
4. Rich M.W., Keller A.J., Schechtman K.B., Marshall Jr. W.G., and Kouchoukos N.T. Morbidity and mortality of coronary bypass surgery in patients 75 years of age or older. Ann Thorac Surg 46 (1988) 638-644
5. Naunheim K.S., Fiore A.C., Arango D.C., et al. Coronary artery bypass grafting for unstable angina pectoris. risk analysis. Ann Thorac Surg 47 (1989) 569-574
6. Stahle E., Bergstrom R., Nystrom S.O., and Hansson H.E. Early results of aortic valve replacement with or without concomitant coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 25 (1991) 29-35
7. Kollef M.H., Wragge T., and Pasque C. Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest 107 (1995) 1395-1401
8. Michalopoulos A., Tzelepis G., Dafni U., and Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest 115 (1999) 1598-1603
9. Bauer E.P., Schonburg M., Schwarz T., Piepho A., and Klovekorn W.P. Valve surgery combined with coronary artery operation. is the use of internal mammary artery a predictor for early complications?. Eur J Cardiothorac Surg 10 (1996) 248-252
10. Cauliez B., Redonnet M., Darras S., et al. Cardiac troponin I and CK-MB mass after cardiac surgery with cardiopulmonary bypass. Ann Biol Clin (Paris) 62 (2004) 41-46
11. Fitzgerald R.L., Frankel W.L., and Herold D.A. Comparison of troponin-T with other cardiac markers in a VA hospital. Am J Clin Pathol 106 (1996) 396-401
12. Kallner G., Lindblom D., Forssell G., and Kallner A. Myocardial release of troponin T after coronary bypass surgery. Scand J Thorac Cardiovasc Surg 28 (1994) 67-72
13. Onorati F., De F.M., Mastroroberto P., et al. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg 79 (2005) 837-845
14. Buckberg G.D. Myocardial protection. entering the new millennium. J Card Surg 17 (2002) 447-450
15. Royston D. Systemic inflammatory responses to surgery with cardiopulmonary bypass. Perfusion 11 (1996) 177-189
16. Rocke D.A., Gaffin S.L., Wells M.T., Koen Y., and Brock-Utine J.G. Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93 (1987) 832-837
17. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 106 (1993) 978-987
18. Fitch J.C., Rollins S., Matis L., et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 100 (1999) 2499-2506
19. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery. postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
20. Seghaye M.C., Engelhardt W., Grabitz R.G., et al. Multiple system organ failure after open heart surgery in infants and children. Thorac Cardiovasc Surg 41 (1993) 49-53
21. Eltzschig H.K., and Collard C.D. Vascular ischaemia and reperfusion injury. Br Med Bull 70 (2004) 71-86
22. Verrier E.D., Shernan S.K., Taylor K.M., et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass. a randomized trial. JAMA 291 (2004) 2319-2327
23. Monti K.L. Folded empirical distribution function curves-mountain plots. Am Stat 49 (1995) 342-345
24. Analysis of the Society of Thoracic Surgeons Adult Cardiac Database provided by the Society of Thoracic Surgeons and the Duke Clinical Research Institute (2005)
25. Chen J.C., Kaul P., Haverich A., et al. Myocardial infarction (MI) following coronary artery bypass graft (CABG) surgery increases intensive care unit time, hospital stay, and overall costs (June 25, 2005), Western Thoracic Surgical Association, Victoria, British Columbia [abstract]
26. Al-Ruzzeh S., Asimakopoulos G., Ambler G., et al. Validation of four different risk stratification systems in patients undergoing off-pump coronary artery bypass surgery. a UK multicentre analysis of 2223 patients. Heart 89 (2003) 432-435
27. Society of Thoracic Surgeons and the Duke Clinical Research Institute. STS 2005 Adult Cardiac Database Executive Summary. Available from: http://www.sts.org/documents/pdf/Spring2005STS-ExecutiveSummary.pdf.
28. Feit F., Brooks M.M., Sopko G., et al., BARI Investigators. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry. comparison with the randomized trial. Circulation 101 (2000) 2795-2802
29. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., DeLong E.R., and Grover F.L. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999. a report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 73 (2002) 480-489
30. Naunheim K.S., Fiore A.C., Wadley J.J., et al. The changing mortality of myocardial revascularization. coronary artery bypass and angioplasty. Ann Thorac Surg 46 (1988) 666-674
31. Verrier E.D. The PRIMO-CABG study. pexelizumab for the reduction of infarction and mortality in coronary artery bypass graft surgery (2003) [abstract]. Scientific Sessions of the American Heart Association; November 9-12; Orlando, Florida
32. Levitsky S., and McCully J.D. Myocardial protection. Sabiston & Spencer surgery of the chest (2005), Elsevier Press, Philadelphia 1081-1102